UK Health Authorities Assessing AstraZeneka Vaccine

0
54

Uk health authorities are assessing the latest vaccine producer to announce that their vaccine has a 70%+ efficacy rate. Although this is not the same as the first two companies to announce their vaccines. Their efficacy rates were in the mid 90% percentile. Another major issue is that scientists are highly sceptical of the claims as they appear to have botched up the trials. They thus consider them to be non-transparent. They also claim that if placed under intense scrutiny they would fail. As the numbers involved in the trials simply do not pass muster. However the UK health authorities are under great pressure as the numbers of cases is one of the worst in the world.. Having a company that has one of its bases as the UK. Is an advantage in getting the production of the vaccine quickly to the UK. They are thus very keen and interested in the vaccine passing peer scrutiny and their methodology of assessment.

Previous articleOutrage Expressed On The Passing Of A Bill To Stop The Filming Of Police
Next articleLand Back Slogan Vandalism On Past Presidents Statues & Store Fronts
Catherine is our Co-Editor. provides insight on educational issues in America, including legal, social and ethical angles. Catherine considers “Objects in the mirror are closer than they appear" to be the answer to every existential question out there. Because, truly, the greatest mistake of them all is to believe that you are educated enough and stop learning. After earning her MSE in Educational Theory and Practice from Arkansas State University, Catherine started working as a reporter. So far, she has devoted 11 years to it, covering K-12 and higher education, editing for Future Knowledge, Academia, Apis Gazette, and The Sacramento Post. Catherine believes that every human has the inherent right to learn and be whoever they aspire to become. She provides insight on educational issues in America, including legal, social and ethical angles. Email:green@democracyforus.org

LEAVE A REPLY

Please enter your comment!
Please enter your name here